Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,882 | 291 | 47.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,207 | 5 | 31.5% |
| Consulting Fee | $2,187 | 3 | 13.2% |
| Travel and Lodging | $838.05 | 6 | 5.1% |
| Education | $429.69 | 6 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $7,020 | 48 | $0 (2023) |
| GENZYME CORPORATION | $3,470 | 26 | $0 (2024) |
| LEO Pharma Inc. | $593.60 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $590.83 | 23 | $0 (2024) |
| ABBVIE INC. | $560.21 | 22 | $0 (2024) |
| Incyte Corporation | $509.86 | 19 | $0 (2024) |
| PFIZER INC. | $501.41 | 21 | $0 (2024) |
| Galderma Laboratories, L.P. | $410.67 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $361.62 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $317.72 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,483 | 51 | GENZYME CORPORATION ($234.57) |
| 2023 | $5,835 | 81 | Regeneron Healthcare Solutions, Inc. ($4,462) |
| 2022 | $7,401 | 102 | GENZYME CORPORATION ($3,081) |
| 2021 | $1,825 | 77 | Galderma Laboratories, L.P. ($373.68) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Immunology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.25 | General |
| Category: Immunology | ||||||
| 10/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Immunology | ||||||
| 10/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/04/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Inflammation & Immunology | ||||||
| 09/27/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA, ARAZLO | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Immunology | ||||||
| 07/23/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: DERMATOLOGY | ||||||
| 06/28/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Dermatology | ||||||
| 06/25/2024 | Lumenis BE inc | Optilight (Device) | Food and Beverage | Cash or cash equivalent | $138.41 | General |
| Category: Opthamology | ||||||
| 06/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.54 | General |
| Category: Dermatology | ||||||
| 06/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $133.73 | General |
| Category: Immunology | ||||||
| 06/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: DERMATOLOGY | ||||||
| 06/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 77 | 123 | $21,300 | $4,656 |
| 2022 | 13 | 425 | 647 | $73,351 | $28,756 |
| 2021 | 16 | 851 | 1,631 | $163,268 | $71,577 |
| 2020 | 14 | 828 | 1,505 | $157,220 | $61,842 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 33 | $8,728 | $2,132 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,912 | $884.63 | 18.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 12 | 12 | $3,793 | $873.39 | 23.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 12 | 14 | $2,850 | $514.76 | 18.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 11 | 49 | $1,017 | $251.36 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 155 | $18,577 | $8,449 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 78 | $14,464 | $6,241 | 43.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 49 | 57 | $11,046 | $4,554 | 41.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 38 | 45 | $3,379 | $1,530 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,614 | $1,309 | 36.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 20 | 20 | $3,908 | $1,269 | 32.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 12 | 12 | $4,092 | $1,132 | 27.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 30 | 34 | $4,727 | $1,107 | 23.4% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 15 | 21 | $2,562 | $941.13 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,523 | $807.31 | 32.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 13 | 17 | $1,649 | $707.34 | 42.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 24 | 141 | $2,686 | $675.76 | 25.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 26 | 41 | $123.00 | $33.38 | 27.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 206 | $36,668 | $17,856 | 48.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 155 | 218 | $25,506 | $14,426 | 56.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 85 | 103 | $19,673 | $8,697 | 44.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $13,066 | $4,664 | 35.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 80 | 109 | $7,957 | $4,141 | 52.0% |
| 96900 | Application of ultraviolet light to skin | Office | 2021 | 11 | 182 | $7,280 | $3,086 | 42.4% |
| 11901 | Injection of more than 7 skin growths | Office | 2021 | 27 | 60 | $7,320 | $3,065 | 41.9% |
About Leah Waller, PA-C
Leah Waller, PA-C is a Physician Assistant healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2015. The National Provider Identifier (NPI) number assigned to this provider is 1740673250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leah Waller, PA-C has received a total of $16,544 in payments from pharmaceutical and medical device companies, with $1,483 received in 2024. These payments were reported across 311 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($7,882).
As a Medicare-enrolled provider, Waller has provided services to 2,181 Medicare beneficiaries, totaling 3,906 services with total Medicare billing of $166,832. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Fredericksburg, VA
- Active Since 03/07/2015
- Last Updated 01/23/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1740673250
Products in Payments
- DUPIXENT (Biological) $10,365
- TREMFYA (Drug) $544.87
- AKLIEF (Drug) $374.31
- ADBRY (Biological) $359.73
- OPZELURA (Drug) $342.15
- EUCRISA (Drug) $328.70
- SKYRIZI (Biological) $310.37
- Sotyktu (Drug) $299.05
- COSENTYX (Biological) $242.34
- ENSTILAR (Drug) $233.87
- VTAMA (Drug) $217.76
- CIBINQO (Drug) $172.71
- RINVOQ (Biological) $170.22
- Winlevi (Drug) $167.44
- TALTZ (Drug) $161.16
- REMICADE (Biological) $146.15
- ZILXI (Drug) $139.68
- Optilight (Device) $138.41
- OLUMIANT (Drug) $89.70
- COSENTYX (Drug) $88.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Fredericksburg
Mr. Jalal Alghabra, Pa, PA
Physician Assistant — Payments: $93,510
Mrs. Denise Hamilton, Pa-C, PA-C
Physician Assistant — Payments: $9,117
Monica Spellman, Pa, PA
Physician Assistant — Payments: $8,922
Neelam Parikh, Pa, PA
Physician Assistant — Payments: $7,139
Stephanie Rosas, Pa-C, PA-C
Physician Assistant — Payments: $6,782
Mr. Stephen Woof, Pa-C Atc, PA-C ATC
Physician Assistant — Payments: $5,350